# SAM #36C25727Q0055

VA North Texas blood products, transfusion testing, and related services IDIQ

**Buyer:** VETERANS AFFAIRS, DEPARTMENT OF
**Posted:** November 03, 2026
**Respond By:** November 13, 2026
**Identifier:** 36C25727Q0055
**NAICS:** 621991, 325414

The Department of Veterans Affairs is seeking blood products and transfusion-related support for North Texas VA facilities through a proposed sole-source contract with Carter BloodCare.
- **Buyer and purpose:** VA Network Contracting Office 17, for the North Texas Veterans Health Care System (VANTHCS), Pathology & Laboratory Medicine Service; services support the Dallas VA Health Care Center and other North Texas locations.
- **Procurement approach:** Notice of intent to award Carter BloodCare a single-award, firm-fixed-price IDIQ. The VA will consider capability information from responsible alternative sources; this notice is not a request for quotations or proposals.
- **Scope:** Blood components, specialized blood products, processing and storage, transfusion and reference-laboratory testing, sample pickup, and therapeutic phlebotomy. Estimated annual requirements include 4,056 leukocyte-reduced red-cell units, 416 leukocyte-reduced apheresis platelet units, 350 plasma units, and other specialized products and services.
- **Key requirements:** Products must meet AABB/FDA requirements. The statement of work calls for urgent and 24-hour delivery, a nearby distribution facility, and contractor-provided personnel, transportation, equipment, materials, and supplies. Therapeutic phlebotomy is available Monday through Friday at multiple North Texas locations.
- **Period:** Five annual ordering periods, with a base period of May 1, 2027–April 30, 2028, and four subsequent 12-month periods through April 30, 2032. The statement of work anticipates a 5% annual fee increase. Quantities are estimates, not guaranteed orders.
- **Quantity caveat:** Some attachment estimates differ for frozen blood storage, STAT reference testing, Zone 2 sample pickup, and therapeutic phlebotomy. The line-item list uses the notice’s X-coded estimates and identifies the alternate statement-of-work quantities where applicable.

### Description

<p>The Department of Veterans Affairs, Network Contracting Office 17, intends to award a Firm-Fixed price, single-award IDIQ to Carter Bloodcare, for procurement of the following Blood and Blood Products (&ldquo;X&rdquo; represents Ordering Periods 1-5):&nbsp;&nbsp;</p>

<p></p>

<p></p>

<p>Item #</p>

<p>Description</p>

<p>Est Annual Needs</p>

<p>Unit</p>

<p>X001</p>

<p>*Red Cells, Leukocyte reduced</p>

<p>4056</p>

<p>Unit</p>

<p>X002</p>

<p>Platelets, Pheresis, Leukocyte reduced</p>

<p>416</p>

<p>Unit</p>

<p>X003</p>

<p>Fresh frozen plasma, OR Plasma frozen &lt;24 hours</p>

<p>350</p>

<p>Unit</p>

<p>X004</p>

<p>Cryoprecipitate, frozen pooled from 5 donors</p>

<p>150</p>

<p>Unit</p>

<p>X005</p>

<p>Platelet-pheresis, HLA matched</p>

<p>5</p>

<p>Unit</p>

<p>X006</p>

<p>Deglycerolyzed Red cells</p>

<p>5</p>

<p>Unit</p>

<p>X007</p>

<p>Freezing of Patient RBC</p>

<p>5</p>

<p>Ea</p>

<p>X008</p>

<p>Deglycerolization of frozen RBC</p>

<p>5</p>

<p>Ea</p>

<p>X009</p>

<p>Irradiation Fee</p>

<p>1000</p>

<p>Ea</p>

<p>X010</p>

<p>Class 1 HLA Type</p>

<p>1</p>

<p>Ea</p>

<p>X011</p>

<p>HLA Typing; A, B, C, single antigen</p>

<p>1</p>

<p>Ea</p>

<p>X012</p>

<p>HLA-A,B, Molecular; Request Coding</p>

<p>1</p>

<p>Ea</p>

<p>X013</p>

<p>HLA Computer match fee</p>

<p>10</p>

<p>Ea</p>

<p>X014</p>

<p>ABID; PLT Immunoglobulin Assay XM</p>

<p>5</p>

<p>Ea</p>

<p>X015</p>

<p>ABID; PLT Immunoglobulin Assay PLA1</p>

<p>1</p>

<p>Ea</p>

<p>X016</p>

<p>ABID; Platelet Antibody</p>

<p>3</p>

<p>Ea</p>

<p>X017</p>

<p>Washing (red blood cells)</p>

<p>3</p>

<p>Ea</p>

<p>X018</p>

<p>Antigen Screen, Tier 1 antigen (C, c, E, or K)</p>

<p>30</p>

<p>Ea</p>

<p>X019</p>

<p>Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1)</p>

<p>50</p>

<p>Ea</p>

<p>X020</p>

<p>Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence)</p>

<p>50</p>

<p>Ea</p>

<p>X021</p>

<p>ABO/Rh type</p>

<p>10</p>

<p>Ea</p>

<p>X022</p>

<p>Blood Typing-ABO/Rh Discrepancy</p>

<p>2</p>

<p>Ea</p>

<p>X023</p>

<p>Antibody Screen, RBC, each Serum Technique</p>

<p>10</p>

<p>Ea</p>

<p>X024</p>

<p>Cold Agglutinin, Screen</p>

<p>1</p>

<p>Ea</p>

<p>X025</p>

<p>AHG Test; Direct,&nbsp; each antiserum</p>

<p>5</p>

<p>Ea</p>

<p>X026</p>

<p>ABID, RBC Antobodies, ea panel</p>

<p>10</p>

<p>Ea</p>

<p>X027</p>

<p>Antibody Elution (RBC), each</p>

<p>6</p>

<p>Ea</p>

<p>X028</p>

<p>Pretreat RBC with Enzymes, each</p>

<p>3</p>

<p>Ea</p>

<p>X029</p>

<p>Pretreat Serum with Absorption x1</p>

<p>2</p>

<p>Ea</p>

<p>X030</p>

<p>Pretreat Serum with Absorption x2</p>

<p>2</p>

<p>Ea</p>

<p>X031</p>

<p>Pretreat Serum with Absorption x3</p>

<p>2</p>

<p>Ea</p>

<p>X032</p>

<p>Drug Studies Request Coding</p>

<p>1</p>

<p>Ea</p>

<p>X033</p>

<p>Lectin Panel (Polyagglutination)</p>

<p>1</p>

<p>Ea</p>

<p>X034</p>

<p>CMV Negative</p>

<p>3</p>

<p>Ea</p>

<p>X035</p>

<p>HgB S Negative</p>

<p>5</p>

<p>Ea</p>

<p>X036</p>

<p>Frozen Blood Storage (up to 90 days)</p>

<p>3</p>

<p>Ea</p>

<p>X037</p>

<p>Imported Rare Unit Fee</p>

<p>5</p>

<p>Ea</p>

<p>X038</p>

<p>Molecular RBC Genotype</p>

<p>20</p>

<p>Ea</p>

<p>X039</p>

<p>RHD Molecular Testing</p>

<p>5</p>

<p>Ea</p>

<p>X040</p>

<p>RhCE Molecular Testing</p>

<p>5</p>

<p>Ea</p>

<p>X041</p>

<p>Molecular Sequencing</p>

<p>1</p>

<p>Ea</p>

<p>X042</p>

<p>STAT Reference Testing Fee</p>

<p>30</p>

<p>Ea</p>

<p>X043</p>

<p>Sample Pick-Up, Time Sensitive</p>

<p>10</p>

<p>Ea</p>

<p>X044</p>

<p>Sample Pick Up &ndash; Zone 2</p>

<p>30</p>

<p>Ea</p>

<p>X045</p>

<p>Therapeutic Phlebotomy Donation</p>

<p>100</p>

<p>Ea</p>

<p>The Dallas Veteran Affairs Health Care Center has a requirement for the supply and delivery of blood and blood products supporting the North Texas Veterans Health Care System (VANTHCS).</p>

<p>Contractor will furnish all personnel, labor, transportation, equipment, materials and supplies necessary to provide Human Blood and Blood Products and guidance in Clinical Pathology Procedures as specified herein for eligible VA beneficiaries of the North Texas Veterans Health Care System, VA North Texas Health Care System, 4500 S. Lancaster Road, Dallas, TX 75216.&nbsp;</p>

<p>This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, by email, to the point of contact and referencing the notice ID 36C25727Q0055, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 21 days from the publication of this notice, a contract/order will be issued to Carter Bloodcare, without any further notice.</p>

<p>The proposed contract action is for supplies for which the Government intends to negotiate with only one source. The statutory authority permitting other than full and open competition is 41 U.S.C. &sect; 3304(a)(1), as implemented by FAR 6.103-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.</p>

<p>The proposed sole source procurement will be made by a pricing agreement with Carter Bloodcare.</p>

<p>See attached document: Statement of Work - Blood and Blood Products for North Texas VA.</p>

[View original listing](https://sam.gov/opp/90060542e9994712ad4262f14a50f1e8/view)